v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Continuing operations:    
Net loss $ (16,565,350) $ (4,353,776)
Income from discontinued operations (96,132) (3,346,992)
Loss from continuing operations (16,661,482) (1,006,784)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities of continuing operations :    
Stock-based compensation 883,943 133,043
Depreciation and amortization 2,156,427 18,133
Deferred income tax benefit (3,053,000)
Amortization of license fee revenue (24,174) (24,175)
Common stock issued for services 20,000
Asset impairment charge 11,480,491
Revaluation of digital currencies 2,467,875
Other non-cash charges 1,500
Changes in assets and liabilities:    
Prepaid contracts (3,584,699)
Prepaid expenses and other current assets 27,438 62,733
Digital currencies (901,380)
Accounts payable 1,101,198 15,950
Accrued expenses 526,590 (202,227)
Net cash used in operating activities of continuing operations (5,560,773) (1,001,827)
Net cash used in operating activities of discontinued operations (68,824) (661,998)
Net cash used in operating activities (5,629,597) (1,663,825)
Continuing operations:    
Purchases of property and equipment (18,922,569)
Purchase of digital currency (5,625,000) 7,506,761
Purchases of other investments (6,412,726)
Security deposits (673,463) (11,911)
Purchases of patent and trademark application costs (24,074)
Investment in Logical Brokerage, net of cash acquired (516,918)
Purchase of developed technology (32,640)
Net cash (used in) provided by investing activities of continuing operations (32,207,390) 7,494,850
Net cash (used in) investing activities of discontinued operations (1,776)
Net cash (used in) provided by investing activities (32,207,390) 7,493,074
Cash flows from financing activities - continuing operations:    
Proceeds from notes payable 775,074 705,974
Repayment of notes payable and other obligations (81,040)
Proceeds from exercise of warrants 350,000 (83,453)
Proceeds from exercise of stock options 78,522
Proceeds from sale of Riot shares held by Tess 320,000
Net cash provided by financing activities of continuing operations 1,442,556 622,521
Net increase (decrease) in cash and cash equivalents (36,394,431) 6,451,770
Cash and cash equivalents at beginning of period 41,651,965 5,529,848
Cash and cash equivalents at end of period 5,257,534 11,981,618
Supplemental disclosure of cash flow information:    
Cash paid for interest 1,219 1,256
Supplemental disclosure of noncash investing and financing activities:    
Value of shares issued for Prive asset acquisition $ 8,480,000
Conversion of Preferred stock to Common stock 2,815,498
Deferred purchase price for BMSS $ 1,500,000

Source